throbber
Design and Synthesis of a Photocleavable Fluorescent Nucleotide
`3¢-O-Allyl-dGTP-PC-Bodipy-FL-510 as a Reversible Terminator for
`DNA Sequencing by Synthesis
`
`Qinglin Meng,†,‡,§ Dae Hyun Kim,†,| Xiaopeng Bai,†,‡,§ Lanrong Bi,†,‡
`Nicholas J. Turro,‡,§ and Jingyue Ju*,†,‡
`Columbia Genome Center, Columbia UniVersity College of Physicians and Surgeons,
`New York, New York 10032, and Departments of Chemical Engineering, Chemistry, and
`Biomedical Engineering, Columbia UniVersity, New York, New York 10027
`
`ju@genomecenter.columbia.edu
`ReceiVed February 14, 2006
`
`DNA sequencing by synthesis (SBS) using reversible fluorescent nucleotide terminators is potentially an
`efficient approach to address the limitations of current DNA sequencing techniques. Here, we report the
`design and synthesis of a 3¢-O-allyl photocleavable fluorescent nucleotide analogue, 3 ¢-O-allyl-dGTP-
`PC-Bodipy-FL-510, as a reversible terminator for SBS. The nucleotide is efficiently incorporated by
`DNA polymerase into a growing DNA strand to terminate the polymerase reaction. After that, the
`fluorophore is photocleaved quantitatively by irradiation at 355 nm, and the allyl group is rapidly and
`efficiently removed by using a Pd-catalyzed reaction under DNA-compatible conditions to regenerate a
`free 3¢-OH group to reinitiate the polymerase reaction. Two cycles of such steps were successfully
`demonstrated to sequence a homopolymeric region of a DNA template, facilitating the development of
`SBS as a viable approach for high-throughput DNA sequencing.
`
`Introduction
`
`DNA sequencing is a fundamental tool for biological research
`and medical diagnostics, driving disease gene discovery and
`gene function studies. DNA sequencing by synthesis (SBS)
`using reversible fluorescent nucleotide terminators1 is a poten-
`tially efficient approach to address the limitations of current
`DNA sequencing techniques, such as throughput and data
`accuracy. We have previously reported the design and synthesis
`of a 3¢-O-allyl photocleavable (PC) fluorescent nucleotide
`analogue, 3¢-O-allyl-dUTP-PC-Bodipy-FL-510, as a reversible
`terminator for SBS.2 The nucleotide can be efficiently incor-
`porated by DNA polymerase into a growing DNA strand to
`
`* To whom correspondence should be addressed. Phone: 212-851-5172.
`Fax: 212-851-5215.
`† Columbia Genome Center, Columbia University College of Physicians and
`Surgeons.
`‡ Department of Chemical Engineering, Columbia University.
`§ Department of Chemistry, Columbia University.
`| Department of Biomedical Engineering, Columbia University.
`(1) Ju, J.; Li, Z.; Edwards, J.; Itagaki, Y. U.S. Patent 6,664,079, 2003.
`
`3248
`
`J. Org. Chem. 2006, 71, 3248-3252
`
`terminate the polymerase reaction. After that, the fluorophore
`can be photocleaved quantitatively by irradiation at 355 nm,
`and the allyl group is rapidly and efficiently removed by using
`a Pd-catalyzed reaction in water to regenerate a free 3¢ -OH group
`to reinitiate the polymerase reaction.
`To the best of our knowledge, using 3¢-modified dGTP as a
`reversible terminator for SBS has not been reported, partly due
`to the difficulty of modifying the 3¢-OH of guanosine by a
`suitable capping group without protecting the guanine base.
`Here, we describe the design and synthesis of a 3¢-O-allyl
`photocleavable fluorescent 7-deaza-dGTP, 3¢ -O-allyl-dGTP-PC-
`Bodipy-FL-510 (10), with a fluorophore attached to the 7
`position of the modified guanine base and its successful
`application as a reversible terminator to determine two repeated
`nucleotide sequences in SBS. Previously, the Pd-catalyzed
`deallylation to regenerate a free 3¢-OH of the DNA extension
`product was carried out in pure water,2 which can destabilize
`
`(2) Ruparel, H.; Bi, L.; Li, Z.; Bai, X.; Kim, D. H.; Turro, N. J.; Ju, J.
`Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 5932-5937.
`
`10.1021/jo060300k CCC: $33.50 © 2006 American Chemical Society
`Published on Web 03/24/2006
`
`
`
`Illumina Ex. 1084
`IPR Petition - USP 10,435,742
`
`

`

`Design and Synthesis of a PhotocleaVable Fluorescent Nucleotide
`
`Synthesis of
`SCHEME 1.
`3¢ -O-Allyl-dGTP-PC-Bodipy-FL-510 (10)
`
`SCHEME 2. DNA Polymerase Extension Reaction Using
`3¢ -O-Allyl-dGTP-PC-Bodipy-FL-510 (10) as a Reversible
`Terminator
`
`the primer-template duplex. We report here the identification
`of a new condition for rapid quantitative deallylation in a buffer
`solution at pH 8.8, which is commonly used for polymerase
`reaction. The successful synthesis of compound 10 as a
`reversible terminator to sequence through a homopolymer
`sequence and the identification of the new deallylation condition
`will facilitate the development of SBS as a viable approach for
`de novo DNA sequencing.
`
`Results and Discussion
`2-Amino-6-methoxy-9-((cid:226)-D-2¢ -deoxyribofuranosyl)-7-deaza-
`purine 1 was chosen as the starting material for the synthesis
`of 3¢ -O-allyl-7-(3-aminoprop-1-ynyl)-7-deaza-dGTP 9 (Scheme
`1). Compound 1 was first protected by isobutyryl chloride to
`yield 2 quantitatively.3 Compound 2 was iodinated at
`the
`7-position by N-iodosuccinimide (NIS) to produce a single
`product 3 in 90% yield, as the 2-acylamino group in the
`nucleobase promotes the formation of 7-substituted product.4
`Compound 3 was deprotected by methanolic sodium methoxide
`to afford 4 in 94% yield. 5¢ -OH of 4 was protected by tert-
`butyldimethylsilyl chloride to produce 5 in 88% yield.5 3¢ -OH
`of 5 was subsequently allylated in CH2Cl2 and 40% aqueous
`
`(3) Seela, F.; Driller, H. Nucl. Nucl. 1989, 8, 1-21.
`(4) Ramzaeva, N.; Seela, F. Hel. Chim. Acta 1995, 78, 1083-1090.
`(5) Ryu, E. K.; Ross, R. J.; Matsushita, T.; MacCoss, M.; Hong, C. I.;
`West, C. R. J. Med. Chem. 1982, 25, 1322-1329.
`
`NaOH solution using tetrabutylammonium bromide as phase-
`transfer catalyst to give a 92% yield of 6 without N2-allylated
`product. Sonogashira cross-coupling reaction of 6 with the
`terminal alkyne catalyzed by Pd(0)/Cu(I) formed 7 in 94%
`yield.6 Next, a one-pot procedure of demethylation7 and
`desilylation of 7 gave a moderate 34% yield of 8. Finally 8
`was transformed into the corresponding triphosphate 3¢ -O-allyl-
`dGTP 9 following established procedures.8 Coupling 9 with PC-
`Bodipy-FL-510 NHS ester9 yielded the target compound, 3¢ -
`O-allyl-dGTP-PC-Bodipy-FL-510 (10).
`For 3¢ -O-allyl-dGTP-PC-Bodipy-FL-510 (10) to act as a
`reversible terminator for SBS, it is important to establish that
`10 can be used to determine a repeated DNA sequence in a
`polymerase reaction. To this end, we performed a polymerase
`DNA extension reaction using 10 as a substrate in solution as
`shown in Scheme 2. This allows the isolation of the DNA
`product at each step for detailed molecular structure character-
`ization by using MALDI-TOF mass spectrometry (MS) as
`shown in Figure 1.
`
`(6) Hobbs, F. W. J. Org. Chem. 1989, 54, 3420-3422.
`(7) Ramasamy, K.; Imarura, N.; Robins, R. K.; Revankar, G. R. J.
`Heterocycl. Chem. 1988, 25, 1893-1898.
`(8) Lee, S. E.; Sidorov, A.; Gourlain, T.; Mignet, N.; Thorpe, S. J.;
`Brazier, J. A.; Dickman, M. J.; Hornby, D. P.; Grasby, J. A.; Williams, D.
`M. Nucleic Acids Res. 2001, 29, 1565-1573.
`(9) Seo, T. S.; Bai, X.; Kim, D. H.; Meng, Q.; Shi, S.; Ruparel, H.; Li,
`Z.; Turro, N. J.; Ju, J. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 5926-
`5931.
`
`J. Org. Chem, Vol. 71, No. 8, 2006 3249
`
`

`

`Meng et al.
`
`peak corresponding to the photocleavage product 12 appears
`as the sole dominant peak at m/z 6552. Figure 1C shows a single
`peak at m/z 6512, which corresponds to a deallylated photo-
`cleavage product 13. The absence of a peak at m/z 6552 proves
`that the deallylation reaction was completed with high efficiency.
`The next extension reaction was carried out by using this
`deallylated photocleavage product 13 as a primer along with
`3¢ -O-allyl-dGTP-PC-Bodipy-FL-510 (10) to yield an extension
`product 14 (Figure 1D). DNA products (15 and 16) from
`photocleavage (Figure 1E) and deallylation (Figure 1F), respec-
`tively, were obtained in a similar manner as described previ-
`ously, thereby completing two entire polymerase extension
`cycles to sequence a homopolymeric region of a template using
`10 as a reversible terminator.
`In summary, we have developed a successful strategy for the
`synthesis of a 3¢ -O-allyl-modified 7-deaza-dGTP bearing a
`photocleavable fluorophore at
`the 7 position. This novel
`nucleotide analogue is shown to be an excellent substrate for
`9(cid:176) N DNA polymerase A485L/Y409V and can be incorporated
`with high efficiency in a polymerase extension reaction. We
`have also demonstrated that complete photocleavage to remove
`the fluorophore is achieved in 10 s on these DNA products.
`Furthermore, we have shown that deallylation can be swiftly
`achieved to near completion under mild reaction conditions in
`an aqueous environment by using a palladium catalyst. Finally,
`we have established that the deallylated DNA product can be
`used as a primer to continue the polymerase reaction and that
`extension, photocleavage, and deallylation can be performed
`with high efficiency. These results provide further proof of the
`feasibility of using the allyl group as a reversible capping moiety
`for the 3¢ -OH of the photocleavable nucleotide analogues for
`SBS, validating the approach we had previously proposed.1
`Thus, the successful engineering of the building blocks of DNA
`with synthetic chemistry will facilitate the development of SBS
`for high-throughput DNA sequencing and genotyping.
`
`Experimental Section
`2-(2-Methylpropanoyl)amino-6-methoxy-9-[3¢ ,5¢ -bis-O-(2-
`methylpropanoyl)-(cid:226)-D-2¢ -deoxyribofuranosyl]-7-deazapurine (2).
`To a stirred suspension of 1 (1.00 g; 3.57 mmol) in anhydrous
`pyridine (35 mL) was added slowly isobutyryl chloride (3.40 mL;
`32.2 mmol) at 0 (cid:176) C. The reaction mixture was stirred at 0 (cid:176) C for
`1 h. Methanol (2 mL) was then added, and the reaction mixture
`was stirred for another 10 min. Then most solvent was removed
`under vacuum. Ethyl acetate (200 mL) and saturated aqueous
`NaHCO3 (50 mL) were added to the residue. The organic layer
`was separated, washed with saturated aqueous NaHCO3 and NaCl,
`respectively, and dried over anhydrous Na2SO4. After evaporation
`of the solvent, the residue was purified by flash column chroma-
`tography over silica gel using ethyl acetate-hexane (1:3(cid:24)2) as the
`eluent to afford 2 as white foam (1.75 g; 99% yield): 1H NMR
`(400 MHz, CD3OD) (cid:228) 7.28 (d, J ) 3.7 Hz, 1H), 6.66 (dd, J ) 5.9,
`8.6 Hz, 1H), 6.51 (d, J ) 3.7 Hz, 1H), 5.41 (m, 1H), 4.33-4.36
`(m, 2H), 4.22 (m, 1H), 4.08 (s, 3H), 2.83-2.96 (m, 2H), 2.54-
`2.70 (m, 2H), 2.48-2.54 (ddd, J ) 2.0, 5.9, 14.2 Hz, 1H), 1.15-
`1.23 (m, 18H); 13C NMR (100 MHz, CD3OD) (cid:228) 178.2, 177.7, 177.4,
`164.2, 153.4, 152.5, 123.4, 103.5, 100.7, 85.2, 83.0, 75.9, 65.0,
`54.4, 37.9, 36.6, 35.0, 34.9, 19.9, 19.3-19.4 (four peaks); HRMS
`(FAB+) calcd for C24H35O7N4 (M + H+) 491.2506, found
`491.2503.
`2-(2-Methylpropanoyl)amino-6-methoxy-7-iodo-9-[3¢ ,5¢ -bis-
`O-(2-methylpropanoyl)-(cid:226)-D-2¢ -deoxyribofuranosyl]-7-deaza-
`purine (3). To a vigorously stirred solution of 2 (1.75 g; 3.57 mmol)
`in anhydrous DMF (27 mL) was added 95% N-iodosuccimide (NIS)
`
`FIGURE 1. Continuous polymerase extension scheme (left) and
`MALDI-TOF MS spectra of the resulting DNA products (right).
`
`A synthetic 100-mer DNA corresponding to a portion of exon
`7 of the human p53 gene was used as a template to perform the
`extension. The sequence in the template immediately adjacent
`to the annealing site of the primer had a repeating sequence of
`3¢ -CC-5¢ . First, a polymerase extension reaction using 10 as a
`terminator along with a primer and the above template was
`performed. After the reaction, a small portion of the DNA
`extension product was characterized by MALDI-TOF MS. The
`rest of the product was irradiated at 355 nm for 10 s to cleave
`the fluorophore from the DNA and then analyzed by MALDI-
`TOF MS. After photocleavage, the DNA product was added to
`a deallylation cocktail [1X Thermopol reaction buffer/Na2PdCl4/
`P(PhSO3Na)3] to remove the 3¢ -allyl group in 30 s to yield
`quantitatively deallylated DNA product. The deallylated DNA
`product with a free 3¢ -OH group regenerated was then used as
`a primer to incorporate 10 in a subsequent second extension
`reaction.
`Figure 1 (right panel) shows a sequential mass spectrum at
`each step of DNA SBS using 10 as a reversible terminator. As
`can be seen from Figure 1A, the MALDI-TOF MS spectrum
`consists of a distinct peak at m/z 7048 corresponding to the
`single-base DNA extension product 11 with 100% incorporation
`efficiency, confirming that the reversible terminator 10 can be
`incorporated base-specifically by DNA polymerase into a
`growing DNA strand. The small peak at m/z 6552 corresponding
`to the photocleavage product is due to the partial cleavage
`caused by the nitrogen laser pulse (337 nm) used for ionization
`in MALDI-TOF MS. Figure 1B shows the photocleavage result
`after 10 s irradiation of the DNA extension product at 355 nm.
`The peak at m/z 7048 has completely disappeared, whereas the
`
`3250 J. Org. Chem., Vol. 71, No. 8, 2006
`
`

`

`Design and Synthesis of a PhotocleaVable Fluorescent Nucleotide
`
`(866 mg; 3.66 mmol). The reaction mixture was stirred at room
`temperature for 22 h, and then most solvent was removed under
`vacuum. Diethyl ether (200 mL) and saturated aqueous NaHCO3
`(50 mL) were added. The organic layer was separated, washed with
`saturated aqueous NaCl, and dried over anhydrous Na2SO4. After
`evaporation of the solvent, the residue was purified by flash column
`chromatography over silica gel using ethyl acetate-hexane (1:3)
`as the eluent to afford 3 as white solid (1.98 g; 90% yield): 1H
`NMR (400 MHz, CD3OD) (cid:228) 7.43 (s, 1H), 6.63 (dd, J ) 6.0, 8.2
`Hz, 1H), 5.41 (m, 1H), 4.33-4.36 (m, 2H), 4.23 (m, 1H), 4.09 (s,
`3H), 2.78-2.94 (m, 2H), 2.57-2.70 (m, 2H), 2.50-2.57 (ddd, J
`) 2.3, 6.0, 14.2 Hz, 1H), 1.17-1.24 (m, 18H); 13C NMR (100
`MHz, CD3OD) (cid:228) 178.3, 177.8, 177.5, 164.3, 153.3, 152.8, 128.6,
`105.2, 85.3, 83.3, 75.8, 65.0, 54.4, 51.8, 38.2, 36.8, 35.2, 35.1, 19.9,
`19.3-19.5 (four peaks); HRMS (FAB+) calcd for C24H34O7N4I
`(M + H+) 617.1472, found 617.1464.
`2-Amino-6-methoxy-7-iodo-9-((cid:226)-D-2¢ -deoxyribofuranosyl)-7-
`deazapurine (4). Compound 3 (1.98 g; 3.21 mmol) was dissolved
`in 0.5 M methanolic CH3ONa (50 mL) and stirred at 65 (cid:176) C for 12
`h. Saturated aqueous NaHCO3 (20 mL) was added, and the mixture
`was stirred for 10 min. Then most of methanol was evaporated,
`and the residue was extracted by ethyl acetate (150 mL). The
`organic layer was washed with saturated aqueous NaHCO3 and
`NaCl, respectively, and dried over anhydrous Na2SO4. After
`evaporation of the solvent, the residue was purified by flash column
`chromatography over silica gel using CH3OH-CH2Cl2 (1:30-15)
`as the eluent to afford 4 as a white solid (1.23 g; 94% yield): 1H
`NMR (400 MHz, CD3OD) (cid:228) 7.17 (s, 1H), 6.36 (dd, J ) 6.0, 8.4
`Hz, 1H), 4.47 (m, 1H), 3.99 (s, 3H), 3.96 (m, 1H), 3.77 (dd, J )
`3.4, 12.0 Hz, 1H), 3.70 (dd, J ) 3.7, 12.0 Hz, 1H), 2.55-2.64
`(ddd, J ) 6.0, 8.4, 13.4 Hz, 1H), 2.20-2.26 (ddd, J ) 2.4, 5.9,
`13.4 Hz, 1H); 13C NMR (100 MHz, CD3OD) (cid:228) 164.7, 160.6, 154.3,
`126.5, 101.6, 88.7, 86.0, 73.0, 63.7, 53.7, 51.3, 41.1; HRMS
`(FAB+) calcd for C12H16O4N4I (M + H+) 407.0216, found
`407.0213.
`2-Amino-6-methoxy-7-iodo-9-[(cid:226)-D-5¢ -O-(tert-butyldimethyl-
`silyl)-2¢ -deoxyribofuranosyl]-7-deazapurine (5). To a stirred
`solution of 4 (1.23 g; 3.02 mmol) and imidazole (494 mg; 7.24
`mmol) in anhydrous DMF (15 mL) was added tert-butyldimethyl-
`silyl chloride (TBDMSCl) (545 mg; 3.51 mmol). The reaction
`mixture was stirred at room temperature for 20 h. Then most solvent
`was removed under vacuum, and the residue was purified by flash
`column chromatography over silica gel using ethyl acetate-hexane
`(1:2(cid:24)0.5) as the eluent to afford 5 as a white foam (1.38 g; 88%
`yield): 1H NMR (400 MHz, CD3OD) (cid:228) 7.23 (s, 1H), 6.49 (dd, J
`) 6.1, 7.7 Hz, 1H), 4.46 (m, 1H), 3.99 (s, 3H), 3.94 (m, 1H), 3.79-
`3.87 (m, 2H), 2.36-2.44 (ddd, J ) 5.8, 7.7, 13.3 Hz, 1H), 2.24-
`2.31 (ddd, J ) 3.1, 6.0, 13.3 Hz, 1H), 0.96 (s, 9H), 0.14 (s, 3H),
`0.13 (s, 3H); 13C NMR (100 MHz, CD3OD) (cid:228) 164.6, 160.7, 154.7,
`125.1, 101.0, 88.2, 84.2, 72.7, 64.7, 53.7, 51.7, 41.9, 26.7, 19.4,
`-5.0, -5.1; HRMS (FAB+) calcd for C18H30O4N4SiI (M + H+)
`521.1081, found 521.1068.
`2-Amino-6-methoxy-7-iodo-9-[(cid:226)-D-3¢ -O-allyl-5¢ -O-(tert-butyl-
`dimethylsilyl)-2¢ -deoxyribofuranosyl]-7-deazapurine (6). To a
`stirred solution of 5 (1.38 g; 2.66 mmol) in CH2Cl2 (80 mL) were
`added tetrabutylammonium bromide (TBAB) (437 mg; 1.33 mmol),
`allyl bromide (1.85 mL, 21.4 mmol), and 40% aqueous NaOH
`solution (40 mL). The reaction mixture was stirred at room
`temperature for 1 h. Ethyl acetate (200 mL) was added, and the
`organic layer was separated. The aqueous layer was extracted with
`ethyl acetate (2 (cid:2) 50 mL). The combined organic layer was washed
`with saturated aqueous NaHCO3 and NaCl, respectively, and dried
`over anhydrous Na2SO4. After evaporation of the solvent, the
`residue was purified by flash column chromatography over silica
`gel using ethyl acetate-hexane (1:3) as the eluent to afford 6 as a
`white solid (1.37 g; 92% yield): 1H NMR (400 MHz, CD3OD) (cid:228)
`7.20 (s, 1H), 6.43 (dd, J ) 6.2, 7.9 Hz, 1H), 5.89-5.99 (m, 1H),
`5.29-5.35 (dm, J ) 17.3 Hz, 1H), 5.16-5.21 (dm, J ) 10.5 Hz,
`1H), 4.24 (m, 1H), 4.01-4.11 (m, 3H), 3.99 (s, 3H), 3.76-3.84
`
`(m, 2H), 2.32-2.44 (m, 2H), 0.95 (s, 9H), 0.14 (s, 3H), 0.13 (s,
`3H); 13C NMR (100 MHz, CDCl3) (cid:228) 163.3, 158.6, 153.6, 134.1,
`123.7, 116.9, 100.6, 84.4, 83.0, 79.1, 70.0, 63.6, 53.3, 51.1, 38.1,
`26.1, 18.5, -5.1, -5.3; HRMS (FAB+) calcd for C21H34O4N4SiI
`(M + H+) 561.1394, found 561.1390.
`2-Amino-6-methoxy-7-{3-[(trifluoroacetyl)amino]prop-1-
`ynyl]-9-[(cid:226)-D-3¢ -O-allyl-5¢ -O-(tert-butyldimethylsilyl)-2¢ -deoxyribo-
`furanosyl}-7-deazapurine (7). To a stirred solution of 6 (1.37 g;
`2.45 mmol) in anhydrous DMF (11 mL) were added tetrakis-
`(triphenylphosphine)palladium(0) (286 mg; 0.245 mmol) and CuI
`(101 mg; 0.532 mmol). The solution was stirred at room temperature
`for 10 min. Then N-propargyltrifluoroacetamide (1.12 g; 7.43 mmol)
`and triethylamine (0.68 mL; 4.90 mmol) were added. The reaction
`was stirred at room temperature for 13 h with exclusion of air and
`light. Most DMF was removed under vacuum, and the residue was
`dissolved in ethyl acetate (100 mL). The solution was washed with
`saturated aqueous NaHCO3 and NaCl, respectively, and dried over
`anhydrous Na2SO4. After evaporation of the solvent, the residue
`was purified by flash column chromatography over silica gel using
`ethyl acetate-hexane (1:3-1.5) and CH3OH-CH2Cl2 (1:30),
`respectively, as the eluent to afford 7 as yellow solid (1.34 g; 94%
`yield): 1H NMR (400 MHz, CD3OD) (cid:228) 7.34 (s, 1H), 6.42 (dd, J
`) 6.2, 7.7 Hz, 1H), 5.88-5.99 (m, 1H), 5.28-5.35 (dm, J ) 17.3
`Hz, 1H), 5.16-5.21 (dm, J ) 10.5 Hz, 1H), 4.29 (s, 2H), 4.24 (m,
`1H), 4.00-4.09 (m, 3H), 3.98 (s, 3H), 3.76-3.84 (m, 2H), 2.32-
`2.45 (m, 2H), 0.94 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H); 13C NMR
`(100 MHz, CD3OD) (cid:228) 165.0, 161.2, 158.1 (q, J ) 36 Hz), 154.2,
`135.6, 125.0, 117.2 (q, J ) 284 Hz), 117.0, 99.2, 97.3, 86.0, 84.6,
`84.5, 80.3, 78.0, 71.0, 64.8, 53.8, 39.0, 30.9, 26.5, 19.3, -5.1, -5.2;
`HRMS (FAB+) calcd for C26H37O5N5F3Si (M + H+) 584.2516,
`found 584.2491.
`3¢ -O-Allyl-7-{3-[(trifluoroacetyl)amino]prop-1-ynyl}-7-deaza-
`2¢ -deoxyguanosine (8). To a stirred solution of 7 (1.34 g; 2.30
`mmol) in anhydrous CH3CN (86 mL) were added NaI (363 mg;
`2.42 mmol) and chlorotrimethylsilane (TMSCl) (0.306 mL; 2.42
`mmol). The reaction was stirred at room temperature for 1 h and
`then at 50 (cid:176) C for 12 h. The solvent was evaporated, and the residue
`was dissolved in anhydrous THF (76 mL). Tetrabutylammonium
`fluoride (TBAF) (1 M) in THF solution (4.80 mL; 4.80 mmol) was
`added, and the reaction was stirred at room temperature for 1 h.
`The solvent was evaporated, and the residue was dissolved in ethyl
`acetate (150 mL). The solution was washed with saturated aqueous
`NaCl and dried over anhydrous Na2SO4. After evaporation of the
`solvent, the residue was purified by flash column chromatography
`over silica gel using CH3OH-ethyl acetate (1:30) as the eluent to
`afford 8 as yellow solid (356 mg; 34% yield): 1H NMR (400 MHz,
`CD3OD) (cid:228) 7.21 (s, 1H), 6.30 (dd, J ) 6.0, 8.4 Hz, 1H), 5.88-5.99
`(m, 1H), 5.28-5.35 (dm, J ) 17.3 Hz, 1H), 5.15-5.20 (dm, J )
`10.5 Hz, 1H), 4.29 (s, 2H), 4.23 (m, 1H), 4.00-4.10 (m, 3H), 3.65-
`3.75 (m, 2H), 2.41-2.49 (ddd, J ) 5.8, 8.4, 13.6 Hz, 1H), 2.34-
`2.40 (ddd, J ) 2.3, 6.0, 13.6 Hz, 1H); 13C NMR (100 MHz,
`CD3OD) (cid:228) 160.9, 158.0 (q, J ) 36 Hz), 154.1, 151.8, 135.6, 124.4,
`117.2 (q, J ) 284 Hz), 117.0, 101.4, 99.7, 86.4, 85.5, 84.8, 80.7,
`78.0, 71.0, 63.7, 38.5, 31.2; HRMS (FAB+) calcd for C19H21O5N5F3
`(M + H+) 456.1495, found 456.1493.
`3¢ -O-Allyl-7-(3-aminoprop-1-ynyl)-7-deaza-2¢ -deoxyguanosine-
`5¢ -triphosphate (9). The procedure is the same as that of preparing
`3¢ -O-allyl-5-(3-aminoprop-1-ynyl)-2¢ -deoxyuridine-5¢ -triphos-
`phate in ref 2 to yield 9 as a colorless syrup: 1H NMR (300 MHz,
`D2O) (cid:228) 7.56 (s, 1H), 6.37 (t, J ) 7.3 Hz, 1H), 5.89-6.02 (m, 1H),
`5.31-5.39 (dm, J ) 17.3 Hz, 1H), 5.21-5.28 (dm, J ) 10.5 Hz,
`1H), 4.49 (s, 2H), 4.32 (m, 1H), 4.06-4.18 (m, 3H), 3.92-3.99
`(m, 2H), 2.44-2.60 (m, 2H);31P NMR (121.4 MHz, D2O) (cid:228) -6.1
`(d, J ) 20.8 Hz, 1P), -10.8 (d, J ) 18.9 Hz, 1P), -21.9 (t, J )
`19.8 Hz, 1P).
`3¢ -O-Allyl-dGTP-PC-Bodipy-FL-510 (10). PC-Bodipy-FL-510
`NHS ester (prepared by the same procedure as in ref 9) (7.2 mg,
`12 (cid:237)mol) in 300 (cid:237)L of acetonitrile was added to a solution of 9 (2
`mg, 3.4 (cid:237)mol) in 300 (cid:237)L of Na2CO3-NaHCO3 aqueous buffer (0.1
`
`J. Org. Chem, Vol. 71, No. 8, 2006 3251
`
`

`

`M, pH 8.5). The reaction mixture was stirred at room temperature
`for 3 h. A preparative silica gel TLC plate was used to separate
`the unreacted PC-Bodipy-FL-510 NHS ester from the fraction
`containing 10 with CHCl3-CH3OH (85:15) as the eluent. The
`product was concentrated further under vacuum and purified with
`reversed-phase HPLC on a 150 (cid:2) 4.6-mm C18 column to obtain
`the pure product 10 (retention time of 34 min). Mobile phase: A,
`8.6 mM triethylamine/100 mM hexafluoroisopropyl alcohol in water
`(pH 8.1); B, methanol. Elution was performed with 100% A
`isocratic over 10 min, followed by a linear gradient of 0-50% B
`for 20 min and then 50% B isocratic over another 20 min. 3¢ -O-
`Allyl-dGTP-PC-Bodipy-FL-510 10 was characterized by the fol-
`lowing primer extension reaction and characterization by MALDI-
`TOF MS.
`Primer Extension Using 3¢ -O-Allyl-dGTP-PC-Bodipy-FL-510
`(10) and Photocleavage of the Extension Product 11. The
`polymerase extension reaction mixture consisted of 60 pmol of
`(5¢ -GTTGATGTACACATTGTCAA-3¢ ), 80 pmol of
`primer
`template (5¢ -TACCCGGAGGCCAAGTACGGCGGG-
`100-mer
`T A C G T C C T T G A C A A T G T G T A C A T C A A C A T -
`C A C C T A C C A C C A T G T C A G T C T C G G T T G -
`GATCCTCTATTGTGTCCGGG-3¢ ), 120 pmol of 3¢ -O-allyl-
`dGTP-PC-Bodipy-FL-510, 1X Thermopol reaction buffer (20 mM
`Tris-HCl/10 mM (NH4)2SO4/10 mM KCl/2 mM MgSO4/0.1%
`Triton X-100, pH 8.8, New England Biolabs), and 6 units of 9(cid:176) N
`Polymerase (exo-)A485L/Y409V in a total volume of 20 (cid:237)L. The
`reaction consisted of 20 cycles at 94 (cid:176) C for 20 s, 46 (cid:176) C for 40 s,
`and 60 (cid:176) C for 90 s. After the reaction, a small portion of the DNA
`extension product was desalted by using ZipTip and analyzed by
`MALDI-TOF MS, which shows a dominant peak at m/z 7048
`corresponding to the DNA product 11. The rest of the product
`mixture was freeze-dried, resuspended in 200 (cid:237)L of deionized water,
`and irradiated at 355 nm for 10 s to cleave the fluorophore from
`the DNA to yield product 12 and then analyzed by MALDI-TOF
`MS (m/z 6552).
`Deallyation of Photocleaved DNA Extension Product 12. DNA
`product 12 (20 pmol) was added to a mixture of degassed 1X
`Thermopol reaction buffer (20 mM Tris-HCl/10 mM (NH4)2SO4/
`
`Meng et al.
`
`10 mM KCl/2 mM MgSO4/0.1% Triton X-100, pH 8.8, 1 (cid:237)L),
`Na2PdCl4 in degassed H2O (7 (cid:237)L, 23 nmol), and P(PhSO3Na)3 in
`degassed H2O (10 (cid:237)L, 176 nmol) to perform the deallylation. The
`reaction mixture was then placed in a heating block and incubated
`at 70 (cid:176) C for 30 s to yield quantitatively deallylated DNA product
`13 and analyzed by MALDI-TOF MS (m/z 6512).
`Primer Extension Reaction Performed with the Deallylated
`DNA Product. The deallylated DNA product 13 was used as a
`primer in a single-base extension reaction. The 20 (cid:237)L: reaction
`mixture consisted of 60 pmol of the deallylated product 13, 80 pmol
`of the 100-mer template (5¢ -TACCCGGAGGCCAAGTACGGC-
`GGGTACGTCCTTGACAATGTGTACATCAACATCACCTACCA-
`CCATGTCAGTCTCGGTTGGATCCTCTATTGTGTCCGGG-3¢ ),
`120 pmol of 3¢ -O-allyl-dGTP-PC-Bodipy-FL-510 (10), and 6 units
`of 9(cid:176) N Polymerase (exo-)A485L/Y409V in a total volume of 20
`(cid:237)L. The reaction consisted of 20 cycles at 94 (cid:176) C for 20 s, 46 (cid:176) C
`for 40 s, and 60 (cid:176) C for 90 s. The DNA extension product 14 was
`desalted by using the ZipTip protocol, and a small portion was
`analyzed by using MALDI-TOF MS (m/z 7429). The remaining
`product was then irradiated with near-UV light (355 nm) for 10 s
`to cleave the fluorophore from the extended DNA product. The
`resulting photocleavage product 15 (m/z 6933) was analyzed by
`using MALDI-TOF MS. Finally, deallylation of the photocleavage
`product 15 was performed using a Pd-catalyzed deallylation reaction
`resulting in a deallylated DNA product 16, which was then analyzed
`by MALDI-TOF MS (m/z 6893).
`
`Acknowledgment. We thank New England Biolabs for
`providing the 9(cid:176) N DNA polymerase. This work was supported
`by NIH Grant Nos. P50 HG002806 and R01 HG003582 and
`the Packard Fellowship for Science and Engineering.
`
`Supporting Information Available: Spectral data for 2-9
`(1H, 13C, and 31P NMR) and general experimental procedures.
`This material
`is available free of charge via the Internet at
`http://pubs.acs.org.
`
`JO060300K
`
`3252 J. Org. Chem., Vol. 71, No. 8, 2006
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket